<?xml version='1.0' encoding='utf-8'?>
<document id="12538813"><sentence text="Inhibition of transporter-mediated hepatic uptake as a mechanism for drug-drug interaction between cerivastatin and cyclosporin A."><entity charOffset="99-111" id="DDI-PubMed.12538813.s1.e0" text="cerivastatin" /><entity charOffset="116-129" id="DDI-PubMed.12538813.s1.e1" text="cyclosporin A" /><pair ddi="false" e1="DDI-PubMed.12538813.s1.e0" e2="DDI-PubMed.12538813.s1.e0" /><pair ddi="false" e1="DDI-PubMed.12538813.s1.e0" e2="DDI-PubMed.12538813.s1.e1" /></sentence><sentence text="The mechanism involved in the clinically relevant drug-drug interaction (DDI) between cerivastatin (CER) and cyclosporin A (CsA) has not yet been clarified"><entity charOffset="86-98" id="DDI-PubMed.12538813.s2.e0" text="cerivastatin" /><entity charOffset="100-103" id="DDI-PubMed.12538813.s2.e1" text="CER" /><entity charOffset="109-122" id="DDI-PubMed.12538813.s2.e2" text="cyclosporin A" /><entity charOffset="124-127" id="DDI-PubMed.12538813.s2.e3" text="CsA" /><pair ddi="false" e1="DDI-PubMed.12538813.s2.e0" e2="DDI-PubMed.12538813.s2.e0" /><pair ddi="false" e1="DDI-PubMed.12538813.s2.e0" e2="DDI-PubMed.12538813.s2.e1" /><pair ddi="false" e1="DDI-PubMed.12538813.s2.e0" e2="DDI-PubMed.12538813.s2.e2" /><pair ddi="false" e1="DDI-PubMed.12538813.s2.e0" e2="DDI-PubMed.12538813.s2.e3" /><pair ddi="false" e1="DDI-PubMed.12538813.s2.e1" e2="DDI-PubMed.12538813.s2.e1" /><pair ddi="false" e1="DDI-PubMed.12538813.s2.e1" e2="DDI-PubMed.12538813.s2.e2" /><pair ddi="false" e1="DDI-PubMed.12538813.s2.e1" e2="DDI-PubMed.12538813.s2.e3" /><pair ddi="false" e1="DDI-PubMed.12538813.s2.e2" e2="DDI-PubMed.12538813.s2.e2" /><pair ddi="false" e1="DDI-PubMed.12538813.s2.e2" e2="DDI-PubMed.12538813.s2.e3" /></sentence><sentence text=" In the present study, we examined the possible roles of transporter-mediated hepatic uptake in this DDI" /><sentence text=" The uptake of [(14)C]CER into human hepatocytes prepared from three different donors was examined"><entity charOffset="15-25" id="DDI-PubMed.12538813.s4.e0" text="[(14)C]CER" /><entity charOffset="22-31" id="DDI-PubMed.12538813.s4.e1" text="CER" /><pair ddi="false" e1="DDI-PubMed.12538813.s4.e0" e2="DDI-PubMed.12538813.s4.e0" /><pair ddi="false" e1="DDI-PubMed.12538813.s4.e0" e2="DDI-PubMed.12538813.s4.e1" /></sentence><sentence text=" Kinetic analyses revealed K(m) values for the uptake of [(14)C]CER within the range of 3 to 18 microM, suggesting that more than 70% of the total uptake at therapeutic CER concentrations was accounted for by a saturable process, i"><entity charOffset="64-66" id="DDI-PubMed.12538813.s5.e0" text="CER" /><entity charOffset="169-171" id="DDI-PubMed.12538813.s5.e1" text="CER" /><pair ddi="false" e1="DDI-PubMed.12538813.s5.e0" e2="DDI-PubMed.12538813.s5.e0" /><pair ddi="false" e1="DDI-PubMed.12538813.s5.e0" e2="DDI-PubMed.12538813.s5.e1" /></sentence><sentence text="e" /><sentence text=", transporter-mediated uptake" /><sentence text=" This uptake was inhibited by CsA with K(i) values of 0"><entity charOffset="30-32" id="DDI-PubMed.12538813.s8.e0" text="CsA" /></sentence><sentence text="3 to 0" /><sentence text="7 microM" /><sentence text=" The uptake of [(14)C]CER was also examined in human organic anion transporting polypeptide-2 (OATP2)-expressing Madin-Darby canine kidney cells (MDCKII)"><entity charOffset="15-25" id="DDI-PubMed.12538813.s11.e0" text="[(14)C]CER" /><entity charOffset="22-31" id="DDI-PubMed.12538813.s11.e1" text="CER" /><pair ddi="false" e1="DDI-PubMed.12538813.s11.e0" e2="DDI-PubMed.12538813.s11.e0" /><pair ddi="false" e1="DDI-PubMed.12538813.s11.e0" e2="DDI-PubMed.12538813.s11.e1" /></sentence><sentence text=" Saturable OATP2-mediated uptake of [(14)C]CER was observed and was also inhibited by CsA, with a K(i) value of 0"><entity charOffset="36-46" id="DDI-PubMed.12538813.s12.e0" text="[(14)C]CER" /><entity charOffset="43-52" id="DDI-PubMed.12538813.s12.e1" text="CER" /><entity charOffset="86-95" id="DDI-PubMed.12538813.s12.e2" text="CsA" /><pair ddi="false" e1="DDI-PubMed.12538813.s12.e0" e2="DDI-PubMed.12538813.s12.e0" /><pair ddi="false" e1="DDI-PubMed.12538813.s12.e0" e2="DDI-PubMed.12538813.s12.e1" /><pair ddi="false" e1="DDI-PubMed.12538813.s12.e0" e2="DDI-PubMed.12538813.s12.e2" /><pair ddi="false" e1="DDI-PubMed.12538813.s12.e1" e2="DDI-PubMed.12538813.s12.e1" /><pair ddi="false" e1="DDI-PubMed.12538813.s12.e1" e2="DDI-PubMed.12538813.s12.e2" /></sentence><sentence text="2 microM" /><sentence text=" These results suggest that the DDI between CER and CsA involves the inhibition of transporter-mediated uptake of CER and, at least in part, its OATP2-mediated uptake"><entity charOffset="44-46" id="DDI-PubMed.12538813.s14.e0" text="CER" /><entity charOffset="114-116" id="DDI-PubMed.12538813.s14.e1" text="CER" /><entity charOffset="52-54" id="DDI-PubMed.12538813.s14.e2" text="CsA" /><pair ddi="false" e1="DDI-PubMed.12538813.s14.e0" e2="DDI-PubMed.12538813.s14.e0" /><pair ddi="false" e1="DDI-PubMed.12538813.s14.e0" e2="DDI-PubMed.12538813.s14.e2" /><pair ddi="false" e1="DDI-PubMed.12538813.s14.e0" e2="DDI-PubMed.12538813.s14.e1" /><pair ddi="false" e1="DDI-PubMed.12538813.s14.e2" e2="DDI-PubMed.12538813.s14.e2" /><pair ddi="false" e1="DDI-PubMed.12538813.s14.e2" e2="DDI-PubMed.12538813.s14.e1" /></sentence><sentence text=" The effect of CsA on the in vitro metabolism of [(14)C]CER was also examined"><entity charOffset="15-18" id="DDI-PubMed.12538813.s15.e0" text="CsA" /><entity charOffset="49-59" id="DDI-PubMed.12538813.s15.e1" text="[(14)C]CER" /><entity charOffset="56-65" id="DDI-PubMed.12538813.s15.e2" text="CER" /><pair ddi="false" e1="DDI-PubMed.12538813.s15.e0" e2="DDI-PubMed.12538813.s15.e0" /><pair ddi="false" e1="DDI-PubMed.12538813.s15.e0" e2="DDI-PubMed.12538813.s15.e1" /><pair ddi="false" e1="DDI-PubMed.12538813.s15.e0" e2="DDI-PubMed.12538813.s15.e2" /><pair ddi="false" e1="DDI-PubMed.12538813.s15.e1" e2="DDI-PubMed.12538813.s15.e1" /><pair ddi="false" e1="DDI-PubMed.12538813.s15.e1" e2="DDI-PubMed.12538813.s15.e2" /></sentence><sentence text=" The metabolism of [(14)C]CER was inhibited by CsA with an IC(50) value of more than 30 microM"><entity charOffset="19-29" id="DDI-PubMed.12538813.s16.e0" text="[(14)C]CER" /><entity charOffset="26-35" id="DDI-PubMed.12538813.s16.e1" text="CER" /><entity charOffset="47-56" id="DDI-PubMed.12538813.s16.e2" text="CsA" /><pair ddi="false" e1="DDI-PubMed.12538813.s16.e0" e2="DDI-PubMed.12538813.s16.e0" /><pair ddi="false" e1="DDI-PubMed.12538813.s16.e0" e2="DDI-PubMed.12538813.s16.e1" /><pair ddi="false" e1="DDI-PubMed.12538813.s16.e0" e2="DDI-PubMed.12538813.s16.e2" /><pair ddi="false" e1="DDI-PubMed.12538813.s16.e1" e2="DDI-PubMed.12538813.s16.e1" /><pair ddi="false" e1="DDI-PubMed.12538813.s16.e1" e2="DDI-PubMed.12538813.s16.e2" /></sentence><sentence text=" From these results, we conclude that the DDI between CER and CsA is mainly due to the inhibition of transporter (at least partly OATP2)-mediated uptake in the liver"><entity charOffset="54-56" id="DDI-PubMed.12538813.s17.e0" text="CER" /><entity charOffset="62-64" id="DDI-PubMed.12538813.s17.e1" text="CsA" /><pair ddi="false" e1="DDI-PubMed.12538813.s17.e0" e2="DDI-PubMed.12538813.s17.e0" /><pair ddi="false" e1="DDI-PubMed.12538813.s17.e0" e2="DDI-PubMed.12538813.s17.e1" /></sentence><sentence text="" /></document>